West Pharmaceutical Services Inc. (WST): Price and Financial Metrics

West Pharmaceutical Services Inc. (WST): $380.00

7.58 (-1.96%)

POWR Rating

Component Grades

Momentum

F

Stability

B

Sentiment

Quality

B

WST Price/Volume Stats

Current price $380.00 52-week high $415.73
Prev. close $387.58 52-week low $310.42
Day low $379.73 Volume 258,204
Day high $384.16 Avg. volume 519,431
50-day MA $381.55 Dividend yield 0.2%
200-day MA $371.23 Market Cap 27.82B

WST Stock Price Chart Interactive Chart >


West Pharmaceutical Services Inc. (WST) Company Bio


West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. Founded in 1923 by Herman O. West and J.R. Wike of Philadelphia, the company is headquartered in Exton, Pennsylvania. In its early years of development, West produced rubber components for packaging injectable drugs, providing a sterile environment for the producers of penicillin and insulin. (Source:Wikipedia)


WST Latest News Stream


Event/Time News Detail
Loading, please wait...

WST Latest Social Stream


Loading social stream, please wait...

View Full WST Social Stream

Latest WST News From Around the Web

Below are the latest news stories about WEST PHARMACEUTICAL SERVICES INC that investors may wish to consider to help them evaluate WST as an investment opportunity.

MMSI or WST: Which Is the Better Value Stock Right Now?

MMSI vs. WST: Which Stock Is the Better Value Option?

Yahoo | December 28, 2023

West Announces First-Quarter 2024 Dividend

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a first-quarter 2024 dividend of $0.20 per share. The dividend will be paid on February 7, 2024, to shareholders of record as of January 31, 2024.

Yahoo | December 6, 2023

West Pharmaceutical's (WST) New Launch to Expand Portfolio

West Pharmaceutical's (WST) latest addition to its portfolio is likely to address the critical need for more drug preparation and delivery options at the point of care.

Yahoo | December 5, 2023

West Receives FDA 510(k) Clearance for Vial2Bag Advanced® 13mm Admixture Device

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration systems, today announced FDA 510(k) clearance and launch of its Vial2Bag Advanced® 13mm admixture device.

Yahoo | December 4, 2023

Reasons to Retain West Pharmaceutical (WST) in Your Portfolio

West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.

Yahoo | November 29, 2023

Read More 'WST' Stories Here

WST Price Returns

1-mo -1.49%
3-mo 9.64%
6-mo -1.20%
1-year 3.84%
3-year 24.84%
5-year 232.89%
YTD 7.98%
2023 49.97%
2022 -49.70%
2021 65.88%
2020 89.05%
2019 54.13%

WST Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full WST Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!